Brown Alumni Group

No managing partner or investment committee chair has been publicly identified. The group appears to operate through an organiser model — likely one or more alumni volunteers who vet and circulate deal opportunities to the broader Brown graduate network. This opacity means external allocators cannot currently diligence the decision-maker's track record or investment authority.

All publicly known positions show the group as a participant in rounds led by established venture capital firms. In the Series A of ianacare, Greycroft led the syndicate; Brown Alumni Group invested alongside 8VC, Slow Ventures, and others without taking a board seat or sole lead designation. The same co-investor pattern held in the Inner Cosmos round.

There is no known investment, governance, or capital-commitment link between the Brown Alumni Group and the Brown University endowment. The group is an independent alumni-run entity, and its investment activity is not reported in any filings associated with the university's investment office.

There is no public indication that the syndicate accepts capital from non-alumni. Its investment model relies on the Brown graduate network for both deal sourcing and investor participation. Without a public-facing website or fundraising disclosures, the group has given no signal that it seeks third-party limited partners.

Confirmed portfolio companies point to a preference for digital health and consumer technology at the seed and Series A stages. The two known positions — ianacare and Inner Cosmos — both fall within health-adjacent technology. There is no disclosed negative sector screen, but the group has no known exposure to deep tech, enterprise SaaS, or capital-intensive sectors like clean energy or biotech.